Drugindustrydaily

View Archived Issues

June 26, 2019

Vol. 18
No. 122

Headlines

AbbVie to Acquire Allergan in Seismic $63 Billion Deal

AbbVie sent shockwaves through the drug industry Tuesday, announcing that it had reached a deal to acquire fellow drug giant Allergan for approximately $63 billion. Read More

Lawmakers Introduce Legislation to Reform OTC Monograph System

A bipartisan group of U.S. lawmakers introduced a bill aimed at increasing the availability of over-the-counter medications to help bring down healthcare costs. Read More

Sharpless Puts Stem Cell Makers on Notice Following Judge’s Smackdown

Acting FDA Commissioner Ned Sharpless issued another warning to violative stem cell manufacturers following a judge’s permanent injunction against two Florida clinics on Tuesday, promising that the agency’s “aggressive oversight” will continue. Read More

Connecticut AG’s Suit Adds to Pharma’s Summer of Discontent

Forty-eight states were involved in a price-fixing investigation that has now led to multi-state and multimillion-dollar litigation against some of the largest generics makers, a newly revealed complaint shows. Read More